ALERT: This system is being upgraded on Tuesday December 12. It will not be available
for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace
will be disabled on Monday December 11, so no new items are to be added to the repository
while the upgrade is in progress. Everything should be back to normal by the end of
day, December 12.
Use of Salvia divinorum in a nationally representative sample.
Abstract
Salvia divinorum has known hallucinogenic effects and is legal in most parts of the
United States. Given that this psychoactive substance has a potential of misuse and
abuse, further data regarding the clinical and psychosocial factors associated with
use are needed.To examine the clinical and psychosocial characteristics associated
with use of salvia.The study uses data from the National Survey on Drug Use and Health,
2008 (N = 55,623).The results of this study suggest that salvia use is most common
among young adults aged 18-25 years as well as individuals who had engaged in risk-taking
behaviors (selling illicit drugs, stealing) or illicit drug use (especially other
hallucinogens/ecstasy). Self-reported depression and anxiety were also associated
with salvia use. CONCLUSIONS/SCIENTIFIC SIGNIFICANCE: The results provide evidence
that salvia use is part of a broader constellation of psychosocial and behavioral
problems among youth and young adults. The accessibility, legal status, and psychoactive
effects of salvia can be a potentially complicating health risk to young people, especially
among those with existing substance use problems.
Type
Journal articleSubject
HumansSalvia
Substance-Related Disorders
Hallucinogens
Risk-Taking
Age Factors
Adolescent
Adult
Female
Male
Self Report
Permalink
https://hdl.handle.net/10161/19980Published Version (Please cite this version)
10.3109/00952990.2011.600397Publication Info
Perron, BE; Ahmedani, BK; Vaughn, MG; Glass, JE; Abdon, A; & Wu, LT (2012). Use of Salvia divinorum in a nationally representative sample. The American journal of drug and alcohol abuse, 38(1). pp. 108-113. 10.3109/00952990.2011.600397. Retrieved from https://hdl.handle.net/10161/19980.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Li-Tzy Wu
Professor in Psychiatry and Behavioral Sciences
Education/Training: Pre- and post-doctoral training in mental health service research,
psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns
Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute
on the Design and Conduct of Randomized Clinical Trials.Director: Duke Community Based
Substance Use Disorder Research Program.Research interests: COVID-19, Opioid misuse,
Opioid overdose, Opioid use disorder

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info